AML originates from clonal evolution of driver and cooperative genetic alterations in multipotent CD34+/CD33− stem cells and/or in committed CD34+/CD33+ myeloid progenitors [8,9,10]. The gene discussed is CD33; the disease is acute myeloid leukemia.